Mahindra Manulife Mid Cap IDCW Payout Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹1,000

Mahindra Manulife Mid Cap IDCW Payout Direct Plan

NAV
₹18.0228
+0.71%
(31 May)
AUM
1,141 Cr
TER
0.63%
Risk
Very High Risk
Rating
Insights
Net Asset Value (NAV) is above its 200 days moving average
Total Expense Ratio (TER) is in the top 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+31.0%
+31.0%
+17.9%
+16.6%
+16.5%
+16.5%
3Y
+40.9%
+40.9%
+32.6%
+32.7%
+41.4%
+41.4%
5Y
+16.7%
+16.7%
+15.9%
+13.1%
+18.4%
+18.4%
ALL
+20.9%
+20.9%
+14.4%
+19.4%
+17.9%
+17.9%
VOL
19.8%
19.8%
17.8%
-
17.6%
17.6%
TER
0.8%
0.8%
0.6%
-
0.4%
0.4%
AUM
₹4,033 Cr
₹4,033 Cr
₹1,141 Cr
-
₹8,072 Cr
₹8,072 Cr
INFO
1.05
1.05
0.81
-
1.02
1.02
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
Mahindra Manulife Mid Cap IDCW Payout (DP)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 30th Apr
Top holdings
The Federal Bank Ltd
3.0%
Max Healthcare Institute Ltd Ordinary Shares
2.9%
Net Receivables / (Payables)
2.9%
Abbott India Ltd
2.8%
Cummins India Ltd
2.7%
Canara Bank
2.6%
Gujarat Fluorochemicals Ltd Ordinary Shares
2.6%
IDFC Ltd
2.5%
Grindwell Norton Ltd Shs Dematerialised
2.5%
REC Ltd
2.5%
Top industry exposure
Consumer Cyclical
20.8%
Industrials
20.0%
Financial Services
16.6%
Basic Materials
15.0%
Healthcare
6.9%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
105%
Lock-in period
-
Exit load
• 1% for redemption within 365 days
Fund objective
The investment objective of the Scheme is to seek to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies. However, there can be no assurance that the investment objective of the Scheme will be achieved.
Fund manager(s)
Manish Lodha
Abhinav Khandelwal

FAQs